← All trials
NCT04999098
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2021
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- Aug 10, 2021
- Last posted
- Aug 10, 2021
- Enrollment
- 75
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- A. Vogel AGLead sponsor
- Medical University of GrazCollaborator
- Medistat Ltd., IsraelCollaborator
- Biodome ClinicalCollaborator
- Clinical Research Centre CONVEXCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.